Effect of body mass index (BMI) on in vitro fertilization (IVF) outcomes in women with polycystic ovary syndrome (PCOS)

dc.authorid0000-0001-8634-360X
dc.contributor.authorFırat, Aysun
dc.date.accessioned2024-07-29T11:25:30Z
dc.date.available2024-07-29T11:25:30Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.description.abstractObjective: Obesity is known to have negative impaction on reproductive health and ovarian functions. It may alter endocrine axis and quality of oocytes, and indirectly effect the success of in vitro fertilization (IVF). Methods: Medical records of patients with polycystic ovary syndrome (PCOS) who were applied for IVF between 2018 and 2024 were reviewed. Demographics, indications for reproductive treatment, IVF outcome parameters and the factors contributing to morbidity of treatment were recorded. Student's test with one-way analysis of variance (ANOVA) and Kruskal-Wallis tests were used to compare the variables. P < 0.05 was considered statistically significant. Results: 186 patients with PCOS were divided as lean (BMI<25 kg/m(2) , control), overweight (BMI 25-30 kg/m(2)) and obese (BMI>30 kg/m(2)). Mean ages and primary infertility rates were similar (both, P > 0.05), but duration of infertility was longer in overweight and obese patients ( P < 0.05). Although patients with higher BMI required more induction dose for the cycle, number of retrieved oocytes did not change significantly, with achieved chemical and clinical pregnancy (each, P > 0.05). Moreover, fertilization rates of transferred oocytes and rates of adverse outcomes during pregnancies were similar in the groups (each, P > 0.05). Although overweight and obese patients with PCOS required more gonadotropin induction for IVF cycle (2311 vs 1920 vs 1752 IU, respectively, P < 0.05), the numbers of metaphase II and fertilized oocytes were seen to be similar with increasing BMI (each, P > 0.05). Conclusion: There is longer infertility duration and a higher requirement for gonadotropins in overweight and obese patients with no effect of BMI on most of IVF parameters such as retrieved oocyte, clinical pregnancy, obstetric complication and delivery rate.
dc.identifier.citationFırat, A. (2024). Effect of body mass index (BMI) on in vitro fertilization (IVF) outcomes in women with polycystic ovary syndrome (PCOS). Journal of Contemporary Medical Sciences, 10(3), 273-276.
dc.identifier.endpage276
dc.identifier.issn2413-0516
dc.identifier.issue3
dc.identifier.startpage273
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12742
dc.identifier.volume10
dc.identifier.wos001263460400016en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.institutionauthorFırat, Aysun
dc.language.isoen
dc.relation.ispartofJournal of Contemporary Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBody Mass Index (BMI)
dc.subjectPolycystic Ovary Syndrome (PCOS)
dc.subjectIn Vitro Fertilization (IVF)
dc.subjectPregnancy
dc.titleEffect of body mass index (BMI) on in vitro fertilization (IVF) outcomes in women with polycystic ovary syndrome (PCOS)
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Fırat-Aysun-2024.pdf
Boyut:
143.44 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: